United States Biotechnology & Medical Research

Neurocrine Biosciences Inc (NBIX)

Track

Over the last 90 days, Neurocrine Biosciences Inc. has seen significant insider selling activity, with a total sell value exceeding $118 million. Notably, multiple large planned and proposed sales were executed by executives including Stephen A. Sherwin and Julie Cooke. The company's stock has experienced a positive 21.9% price change over the past 90 days.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: NBIX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

SHERWIN STEPHEN A

5 sales — total 500,000 USD

Planned sale 5 Jun 2026

Value US$4,045,073.15 | Price 57.76 | Shares 36,571

Planned sale 5 Jun 2026

Value US$4,637,330.45 | Price 166.42 | Shares 12,288

Planned sale 5 Jun 2026

Value US$100,000.00 | Price 165.79 | Shares 1,000

Planned sale 5 Jun 2026

Value US$100,000.00 | Price 164.44 | Shares 1,000

Planned sale 5 Jun 2026

Value US$100,000.00 | Price 163.81 | Shares 1,000

STEPHEN SHERWIN

Director

2 sales — total 200,000 USD

Proposed sale 5 Jun 2026

Value US$73,391.20 | Price 255.92 | Shares 9,786

Proposed sale 5 Jun 2026

Value US$977,652.93 | Price 320.30 | Shares 86,111

Norwalk Leslie V

1 sale — total 100,000 USD

Planned sale 4 Jun 2026

Value US$100,000.00 | Price 168.06 | Shares 1,000

Cooke Julie

Chief Human Resources Officer

5 sales — total 5,770,235 USD

Planned sale 2 Jun 2026

Value US$558,235.74 | Price 158.59 | Shares 3,520

Planned sale 2 Jun 2026

Value US$1,500,662.89 | Price 157.62 | Shares 9,521

Planned sale 2 Jun 2026

Value US$660,925.46 | Price 156.77 | Shares 4,216

Planned sale 2 Jun 2026

Value US$849,725.78 | Price 155.46 | Shares 5,466

Planned sale 2 Jun 2026

Value US$2,200,685.39 | Price 154.83 | Shares 14,214

JULIE COOKE

Officer

1 sale — total 5,946,857 USD

Proposed sale 2 Jun 2026

Value US$5,946,857.00 | Price 161.00 | Shares 36,937

Onyia Jude

Chief Scientific Officer

1 sale — total 1,762,710 USD

Planned sale 1 Jun 2026

Value US$1,762,710.40 | Price 160.25 | Shares 11,000

JUDE ONYIA

Officer

1 sale — total 1,741,300 USD

Proposed sale 1 Jun 2026

Value US$1,741,300.00 | Price 158.30 | Shares 11,000

Delaet Ingrid

Chief Regulatory Officer

1 sale — total 354,321 USD

Planned sale 29 May 2026

Value US$354,321.31 | Price 156.71 | Shares 2,261

INGRID DELAET

Officer

1 sale — total 353,598 USD

Proposed sale 29 May 2026

Value US$353,597.79 | Price 156.39 | Shares 2,261

Onyia Jude

Chief Scientific Officer

1 sale — total 1,710,865 USD

Planned sale 27 May 2026

Value US$1,710,865.20 | Price 155.53 | Shares 11,000

JUDE ONYIA

Officer

1 sale — total 1,713,030 USD

Proposed sale 27 May 2026

Value US$1,713,030.00 | Price 155.73 | Shares 11,000

Boyer David W.

Chief Corp. Affairs Officer

1 sale — total 609,023 USD

Planned sale 26 May 2026

Value US$609,023.32 | Price 156.64 | Shares 3,888

DAVID WARREN BOYER

Officer

1 sale — total 609,250 USD

Proposed sale 26 May 2026

Value US$609,249.60 | Price 156.70 | Shares 3,888

GORMAN KEVIN CHARLES

1 sale — total 37,824,872 USD

Planned sale 19 May 2026

Value US$37,824,872.20 | Price 154.33 | Shares 245,088

KEVIN CHARLES GORMAN

Director

1 sale — total 38,530,284 USD

Proposed sale 19 May 2026

Value US$38,530,284.48 | Price 157.21 | Shares 245,088

POPS RICHARD F

1 sale — total 2,364,761 USD

Planned sale 15 May 2026

Value US$2,364,760.50 | Price 157.65 | Shares 15,000

RICHARD F POPS

Director

2 sales — total 4,771,500 USD

Proposed sale 15 May 2026

Value US$2,385,750.00 | Price 159.05 | Shares 15,000

Proposed sale 15 May 2026

Value US$2,385,750.00 | Price 159.05 | Shares 15,000

Norwalk Leslie V

2 sales — total 1,618,651 USD

Planned sale 12 May 2026

Value US$590,601.05 | Price 155.01 | Shares 3,810

Proposed sale 12 May 2026

Value US$1,028,050.00 | Price 162.92 | Shares 6,310

Gano Kyle

Chief Executive Officer

2 sales — total 4,830,458 USD

Planned sale 16 Jan 2026

Value US$240,478.31 | Price 132.71 | Shares 1,812

Planned sale 16 Jan 2026

Value US$4,589,979.79 | Price 132.70 | Shares 34,588

KYLE GANO

Officer

1 sale — total 4,853,940 USD

Proposed sale 16 Jan 2026

Value US$4,853,940.00 | Price 133.35 | Shares 36,400

Norwalk Leslie V

1 sale — total 184,558 USD

Planned sale 16 Dec 2025

Value US$184,558.41 | Price 155.09 | Shares 1,190

Norwalk Leslie V

2 sales — total 2,506,144 USD

Planned sale 15 Dec 2025

Value US$761,143.50 | Price 152.23 | Shares 5,000

Proposed sale 15 Dec 2025

Value US$1,745,000.00 | Price 155.11 | Shares 11,250

Lippoldt Darin

Chief Legal Officer

1 sale — total 698,615 USD

Planned sale 8 Dec 2025

Value US$698,615.27 | Price 159.65 | Shares 4,376

DARIN LIPPOLDT

Officer

1 sale — total 680,512 USD

Proposed sale 8 Dec 2025

Value US$680,511.76 | Price 155.51 | Shares 4,376

LYONS GARY A

1 sale — total 2,289,083 USD

Planned sale 3 Dec 2025

Value US$2,289,082.50 | Price 152.61 | Shares 15,000

GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012

Director

1 sale — total 2,287,200 USD

Proposed sale 3 Dec 2025

Value US$2,287,200.00 | Price 152.48 | Shares 15,000

BENEVICH ERIC

Chief Commercial Officer

1 sale — total 905,881 USD

Planned sale 28 Nov 2025

Value US$905,880.64 | Price 151.74 | Shares 5,970

ERIC BENEVICH

Officer

1 sale — total 904,933 USD

Proposed sale 28 Nov 2025

Value US$904,932.60 | Price 151.58 | Shares 5,970

MORROW GEORGE J

1 sale — total 2,150,513 USD

Planned sale 25 Nov 2025

Value US$2,150,512.50 | Price 143.37 | Shares 15,000

GEORGE MORROW

Director

1 sale — total 2,118,750 USD

Proposed sale 25 Nov 2025

Value US$2,118,750.00 | Price 141.25 | Shares 15,000

RASTETTER WILLIAM H

1 sale — total 2,732,690 USD

Planned sale 5 Nov 2025

Value US$2,732,689.80 | Price 151.82 | Shares 18,000

WILLIAM H. RASTETTER

Director

1 sale — total 2,577,420 USD

Proposed sale 5 Nov 2025

Value US$2,577,420.00 | Price 143.19 | Shares 18,000

Gano Kyle

Officer; Director

2 sales — total 85,182 USD

Proposed sale 4 Nov 2025

Value US$42,591.00 | Price 141.97 | Shares 300

Planned sale 4 Nov 2025

Value US$42,591.00 | Price 141.97 | Shares 300

GORMAN KEVIN CHARLES

1 sale — total 13,440,281 USD

Planned sale 7 Aug 2025

Value US$13,440,280.97 | Price 126.41 | Shares 106,322

KEVIN CHARLES GORMAN

Director

1 sale — total 13,654,934 USD

Proposed sale 7 Aug 2025

Value US$13,654,934.46 | Price 128.43 | Shares 106,322

Delaet Ingrid

Chief Regulatory Officer

1 sale — total 61,695 USD

Planned sale 10 Jul 2025

Value US$61,695.00 | Price 135.00 | Shares 457

INGRID DELAET

Officer

1 sale — total 61,014 USD

Proposed sale 10 Jul 2025

Value US$61,014.07 | Price 133.51 | Shares 457

Onyia Jude

Chief Scientific Officer

1 sale — total 7,803,688 USD

Planned sale 9 Jul 2025

Value US$7,803,687.64 | Price 130.46 | Shares 59,819

Onyia Jude

Chief Scientific Officer

1 sale — total 2,649,738 USD

Planned sale 2 Jul 2025

Value US$2,649,737.60 | Price 130.13 | Shares 20,362

JUDE ONYIA

Officer

1 sale — total 10,263,168 USD

Proposed sale 2 Jul 2025

Value US$10,263,168.00 | Price 128.00 | Shares 80,181

GORMAN KEVIN CHARLES

1 sale — total 1,157,211 USD

Planned sale 27 May 2025

Value US$1,157,211.02 | Price 120.38 | Shares 9,613

KEVIN CHARLES GORMAN

Director

1 sale — total 1,155,290 USD

Proposed sale 27 May 2025

Value US$1,155,290.34 | Price 120.18 | Shares 9,613

RASTETTER WILLIAM H

1 sale — total 3,305,952 USD

Planned sale 5 May 2025

Value US$3,305,952.00 | Price 110.20 | Shares 30,000

WILLIAM H. RASTETTER

Officer

1 sale — total 3,290,400 USD

Proposed sale 5 May 2025

Value US$3,290,400.00 | Price 109.68 | Shares 30,000

EIRY WYN ROBERTS

Officer

1 sale — total 57,521 USD

Proposed sale 14 Feb 2025

Value US$57,521.25 | Price 115.04 | Shares 500

ROBERTS EIRY

Chief Medical Officer

1 sale — total 57,521 USD

Sale 14 Feb 2025

Value US$57,521.25 | Price 115.04 | Shares 500

Cooke Julie

Chief Human Resources Officer

2 sales — total 181,129 USD

Planned sale 13 Feb 2025

Value US$88,183.09 | Price 116.80 | Shares 755

Planned sale 13 Feb 2025

Value US$92,946.05 | Price 116.77 | Shares 796

GORMAN KEVIN CHARLES

2 sales — total 681,914 USD

Planned sale 13 Feb 2025

Value US$351,449.80 | Price 116.68 | Shares 3,012

Planned sale 13 Feb 2025

Value US$330,464.66 | Price 116.69 | Shares 2,832

SHERWIN STEPHEN A

1 sale — total 1,613,923 USD

Planned sale 13 Feb 2025

Value US$1,613,922.79 | Price 116.69 | Shares 13,831

ROBERTS EIRY

Chief Medical Officer

2 sales — total 200,742 USD

Planned sale 13 Feb 2025

Value US$70,510.42 | Price 116.74 | Shares 604

Planned sale 13 Feb 2025

Value US$130,232.06 | Price 116.90 | Shares 1,114

Onyia Jude

Chief Scientific Officer

2 sales — total 336,239 USD

Planned sale 13 Feb 2025

Value US$168,933.05 | Price 116.75 | Shares 1,447

Planned sale 13 Feb 2025

Value US$167,305.57 | Price 116.83 | Shares 1,432

Lippoldt Darin

Chief Legal Officer

2 sales — total 254,992 USD

Planned sale 13 Feb 2025

Value US$126,789.96 | Price 116.75 | Shares 1,086

Planned sale 13 Feb 2025

Value US$128,202.48 | Price 116.76 | Shares 1,098

Gano Kyle

Chief Executive Officer

2 sales — total 298,908 USD

Planned sale 13 Feb 2025

Value US$140,933.88 | Price 116.86 | Shares 1,206

Planned sale 13 Feb 2025

Value US$157,974.17 | Price 116.84 | Shares 1,352

Delaet Ingrid

Chief Regulatory Officer

2 sales — total 171,674 USD

Planned sale 13 Feb 2025

Value US$88,124.66 | Price 116.72 | Shares 755

Planned sale 13 Feb 2025

Value US$83,549.47 | Price 116.69 | Shares 716

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-09	2026-06-05	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	36,571 +2.8% 57.76 US$4,045,073	36,571 +2.8%	57.76	US$4,045,073
2026-06-09	2026-06-05	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	12,288 +46.5% 166.42 US$4,637,330	12,288 +46.5%	166.42	US$4,637,330
2026-06-09	2026-06-05	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	7,160 +16.6% 11.90 US$86,384	7,160 +16.6%	11.90	US$86,384
2026-06-09	2026-06-05	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	1,000 -7.7% 164.44 US$100,000	1,000 -7.7%	164.44	US$100,000
2026-06-09	2026-06-05	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	1,000 -19.3% 163.81 US$100,000	1,000 -19.3%	163.81	US$100,000
2026-06-05	2026-06-05	PrS Proposed sale	3.1 STEPHEN SHERWIN Director Non-Executive Director	1,000 167.35 US$100,000	1,000	167.35	US$100,000
2026-06-05	2026-06-05	PrS Proposed sale	3.1 STEPHEN SHERWIN Director Non-Executive Director	1,000 167.35 US$100,000	1,000	167.35	US$100,000
2026-06-08	2026-06-04	PlS Planned sale	Norwalk Leslie V Non-Executive Director	1,000 -30.6% 168.06 US$100,000	1,000 -30.6%	168.06	US$100,000
2026-06-04	2026-06-02	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	3,520 -13.6% 158.59 US$558,236	3,520 -13.6%	158.59	US$558,236
2026-06-04	2026-06-02	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	9,521 -26.9% 157.62 US$1,500,663	9,521 -26.9%	157.62	US$1,500,663
2026-06-04	2026-06-02	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	4,216 -10.6% 156.77 US$660,925	4,216 -10.6%	156.77	US$660,925
2026-06-04	2026-06-02	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	5,466 -12.1% 155.46 US$849,726	5,466 -12.1%	155.46	US$849,726
2026-06-04	2026-06-02	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	14,214 -24.0% 154.83 US$2,200,685	14,214 -24.0%	154.83	US$2,200,685
2026-06-02	2026-06-02	PrS Proposed sale	JULIE COOKE Officer Officer	36,937 161.00 US$5,946,857	36,937	161.00	US$5,946,857
2026-06-02	2026-06-01	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	11,000 -29.9% 160.25 US$1,762,710	11,000 -29.9%	160.25	US$1,762,710
2026-06-01	2026-06-01	PrS Proposed sale	3.4 JUDE ONYIA Officer Officer	11,000 158.30 US$1,741,300	11,000	158.30	US$1,741,300
2026-06-02	2026-05-29	PlS Planned sale	Delaet Ingrid Chief Regulatory Officer Officer	2,261 -12.2% 156.71 US$354,321	2,261 -12.2%	156.71	US$354,321
2026-05-29	2026-05-29	PrS Proposed sale	INGRID DELAET Officer Officer	2,261 156.39 US$353,598	2,261	156.39	US$353,598
2026-05-29	2026-05-27	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	11,000 -29.9% 155.53 US$1,710,865	11,000 -29.9%	155.53	US$1,710,865
2026-05-27	2026-05-27	PrS Proposed sale	3.4 JUDE ONYIA Officer Officer	11,000 155.73 US$1,713,030	11,000	155.73	US$1,713,030
2026-05-28	2026-05-26	PlS Planned sale	Boyer David W. Chief Corp. Affairs Officer Officer	3,888 -33.3% 156.64 US$609,023	3,888 -33.3%	156.64	US$609,023
2026-05-26	2026-05-26	PrS Proposed sale	DAVID WARREN BOYER Officer Officer	3,888 156.70 US$609,250	3,888	156.70	US$609,250
2026-05-21	2026-05-19	PlS Planned sale	3.1 GORMAN KEVIN CHARLES Non-Executive Director	245,088 -32.4% 154.33 US$37,824,872	245,088 -32.4%	154.33	US$37,824,872
2026-05-19	2026-05-19	PrS Proposed sale	3.1 KEVIN CHARLES GORMAN Director Non-Executive Director	245,088 157.21 US$38,530,284	245,088	157.21	US$38,530,284
2026-05-18	2026-05-15	PlS Planned sale	2.7 POPS RICHARD F Non-Executive Director	15,000 -30.3% 157.65 US$2,364,760	15,000 -30.3%	157.65	US$2,364,760
2026-05-15	2026-05-15	PrS Proposed sale	2.7 RICHARD F POPS Director Non-Executive Director	15,000 159.05 US$2,385,750	15,000	159.05	US$2,385,750
2026-05-15	2026-05-15	PrS Proposed sale	2.7 RICHARD F POPS Director Non-Executive Director	15,000 159.05 US$2,385,750	15,000	159.05	US$2,385,750
2026-05-14	2026-05-12	PlS Planned sale	Norwalk Leslie V Non-Executive Director	3,810 -61.1% 155.01 US$590,601	3,810 -61.1%	155.01	US$590,601
2026-05-12	2026-05-12	PrS Proposed sale	Norwalk Leslie V Director Non-Executive Director	6,310 162.92 US$1,028,050	6,310	162.92	US$1,028,050
2026-01-20	2026-01-16	PlS Planned sale	Gano Kyle Chief Executive Officer Executive Director	1,812 -1.3% 132.71 US$240,478	1,812 -1.3%	132.71	US$240,478
2026-01-20	2026-01-16	PlS Planned sale	Gano Kyle Chief Executive Officer Executive Director	34,588 -19.8% 132.70 US$4,589,980	34,588 -19.8%	132.70	US$4,589,980
2026-01-16	2026-01-16	PrS Proposed sale	KYLE GANO Officer Officer	36,400 133.35 US$4,853,940	36,400	133.35	US$4,853,940
2025-12-17	2025-12-16	PlS Planned sale	Norwalk Leslie V Non-Executive Director	1,190 -16.0% 155.09 US$184,558	1,190 -16.0%	155.09	US$184,558
2025-12-17	2025-12-15	PlS Planned sale	Norwalk Leslie V Non-Executive Director	5,000 -40.2% 152.23 US$761,144	5,000 -40.2%	152.23	US$761,144
2025-12-15	2025-12-15	PrS Proposed sale	Norwalk Leslie V Director Non-Executive Director	11,250 155.11 US$1,745,000	11,250	155.11	US$1,745,000
2025-12-10	2025-12-08	PlS Planned sale	Lippoldt Darin Chief Legal Officer Officer	4,376 -9.2% 159.65 US$698,615	4,376 -9.2%	159.65	US$698,615
2025-12-08	2025-12-08	PrS Proposed sale	DARIN LIPPOLDT Officer Officer	4,376 155.51 US$680,512	4,376	155.51	US$680,512
2025-12-04	2025-12-03	PlS Planned sale	2.2 LYONS GARY A Non-Executive Director	15,000 -11.1% 152.61 US$2,289,082	15,000 -11.1%	152.61	US$2,289,082
2025-12-03	2025-12-03	PrS Proposed sale	2.2 GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012 Director Non-Executive Director	15,000 152.48 US$2,287,200	15,000	152.48	US$2,287,200
2025-12-02	2025-11-28	PlS Planned sale	BENEVICH ERIC Chief Commercial Officer Officer	5,970 -11.7% 151.74 US$905,881	5,970 -11.7%	151.74	US$905,881
2025-11-28	2025-11-28	PrS Proposed sale	ERIC BENEVICH Officer Officer	5,970 151.58 US$904,933	5,970	151.58	US$904,933
2025-11-26	2025-11-25	PlS Planned sale	2.8 MORROW GEORGE J Non-Executive Director	15,000 -68.0% 143.37 US$2,150,512	15,000 -68.0%	143.37	US$2,150,512
2025-11-25	2025-11-25	PrS Proposed sale	2.8 GEORGE MORROW Director Non-Executive Director	15,000 141.25 US$2,118,750	15,000	141.25	US$2,118,750
2025-11-06	2025-11-05	PlS Planned sale	3.0 RASTETTER WILLIAM H Non-Executive Director	18,000 -30.8% 151.82 US$2,732,690	18,000 -30.8%	151.82	US$2,732,690
2025-11-05	2025-11-05	PrS Proposed sale	3.0 WILLIAM H. RASTETTER Director Non-Executive Director	18,000 143.19 US$2,577,420	18,000	143.19	US$2,577,420
2025-11-05	2025-11-04	PrS Proposed sale	Gano Kyle Officer; Director Executive Director	300 141.97 US$42,591	300	141.97	US$42,591
2025-11-04	2025-11-04	PlS Planned sale	Gano Kyle Chief Executive Officer Executive Director	300 -0.2% 141.97 US$42,591	300 -0.2%	141.97	US$42,591
2025-08-11	2025-08-07	PlS Planned sale	3.1 GORMAN KEVIN CHARLES Non-Executive Director	106,322 -17.1% 126.41 US$13,440,281	106,322 -17.1%	126.41	US$13,440,281
2025-08-07	2025-08-07	PrS Proposed sale	3.1 KEVIN CHARLES GORMAN Director Non-Executive Director	106,322 128.43 US$13,654,934	106,322	128.43	US$13,654,934
2025-07-11	2025-07-10	PlS Planned sale	Delaet Ingrid Chief Regulatory Officer Officer	457 -8.8% 135.00 US$61,695	457 -8.8%	135.00	US$61,695
2025-07-10	2025-07-10	PrS Proposed sale	INGRID DELAET Officer Officer	457 133.51 US$61,014	457	133.51	US$61,014
2025-07-11	2025-07-09	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	59,819 -76.6% 130.46 US$7,803,688	59,819 -76.6%	130.46	US$7,803,688
2025-07-07	2025-07-02	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	20,362 -52.7% 130.13 US$2,649,738	20,362 -52.7%	130.13	US$2,649,738
2025-07-02	2025-07-02	PrS Proposed sale	3.4 JUDE ONYIA Officer Officer	80,181 128.00 US$10,263,168	80,181	128.00	US$10,263,168
2025-05-29	2025-05-27	PlS Planned sale	3.1 GORMAN KEVIN CHARLES Non-Executive Director	9,613 -1.8% 120.38 US$1,157,211	9,613 -1.8%	120.38	US$1,157,211
2025-05-27	2025-05-27	PrS Proposed sale	3.1 KEVIN CHARLES GORMAN Director Non-Executive Director	9,613 120.18 US$1,155,290	9,613	120.18	US$1,155,290
2025-05-07	2025-05-05	PlS Planned sale	3.0 RASTETTER WILLIAM H Non-Executive Director	30,000 -44.5% 110.20 US$3,305,952	30,000 -44.5%	110.20	US$3,305,952
2025-05-05	2025-05-05	PrS Proposed sale	3.0 WILLIAM H. RASTETTER Officer Officer	30,000 109.68 US$3,290,400	30,000	109.68	US$3,290,400
2025-02-14	2025-02-14	PrS Proposed sale	1.6 EIRY WYN ROBERTS Officer Officer	500 115.04 US$57,521	500	115.04	US$57,521
2025-02-14	2025-02-14	S Sale	1.6 ROBERTS EIRY Chief Medical Officer Officer	500 -1.4% 115.04 US$57,521	500 -1.4%	115.04	US$57,521
2025-02-14	2025-02-13	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	755 -3.6% 116.80 US$88,183	755 -3.6%	116.80	US$88,183
2025-02-14	2025-02-13	PlS Planned sale	Cooke Julie Chief Human Resources Officer Officer	796 -3.9% 116.77 US$92,946	796 -3.9%	116.77	US$92,946
2025-02-14	2025-02-13	PlS Planned sale	3.1 GORMAN KEVIN CHARLES Non-Executive Director	3,012 -0.6% 116.68 US$351,450	3,012 -0.6%	116.68	US$351,450
2025-02-14	2025-02-13	PlS Planned sale	3.1 GORMAN KEVIN CHARLES Non-Executive Director	2,832 -0.5% 116.69 US$330,465	2,832 -0.5%	116.69	US$330,465
2025-02-14	2025-02-13	PlS Planned sale	3.1 SHERWIN STEPHEN A Non-Executive Director	13,831 -56.4% 116.69 US$1,613,923	13,831 -56.4%	116.69	US$1,613,923
2025-02-14	2025-02-13	PlS Planned sale	1.6 ROBERTS EIRY Chief Medical Officer Officer	604 -1.7% 116.74 US$70,510	604 -1.7%	116.74	US$70,510
2025-02-14	2025-02-13	PlS Planned sale	1.6 ROBERTS EIRY Chief Medical Officer Officer	1,114 -3.1% 116.90 US$130,232	1,114 -3.1%	116.90	US$130,232
2025-02-14	2025-02-13	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	1,447 -7.4% 116.75 US$168,933	1,447 -7.4%	116.75	US$168,933
2025-02-14	2025-02-13	PlS Planned sale	3.4 Onyia Jude Chief Scientific Officer Officer	1,432 -7.8% 116.83 US$167,306	1,432 -7.8%	116.83	US$167,306
2025-02-14	2025-02-13	PlS Planned sale	Lippoldt Darin Chief Legal Officer Officer	1,086 -2.4% 116.75 US$126,790	1,086 -2.4%	116.75	US$126,790
2025-02-14	2025-02-13	PlS Planned sale	Lippoldt Darin Chief Legal Officer Officer	1,098 -2.5% 116.76 US$128,202	1,098 -2.5%	116.76	US$128,202
2025-02-14	2025-02-13	PlS Planned sale	Gano Kyle Chief Executive Officer Executive Director	1,206 -0.9% 116.86 US$140,934	1,206 -0.9%	116.86	US$140,934
2025-02-14	2025-02-13	PlS Planned sale	Gano Kyle Chief Executive Officer Executive Director	1,352 -1.0% 116.84 US$157,974	1,352 -1.0%	116.84	US$157,974
2025-02-14	2025-02-13	PlS Planned sale	Delaet Ingrid Chief Regulatory Officer Officer	755 -13.8% 116.72 US$88,125	755 -13.8%	116.72	US$88,125
2025-02-14	2025-02-13	PlS Planned sale	Delaet Ingrid Chief Regulatory Officer Officer	716 -14.9% 116.69 US$83,549	716 -14.9%	116.69	US$83,549

Explore more

More insider trading research around Neurocrine Biosciences Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Neurocrine Biosciences Inc (NBIX)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more